Cargando…
SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
Prostate cancer is the most commonly diagnosed malignancy for men in the United States. Metastatic prostate cancer, the lethal form of the disease, has a life expectancy of approximately five years. Identification of factors associated with this transition to metastatic disease is crucial for future...
Autores principales: | Bloom, Jordan E., McNeel, Douglas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239454/ https://www.ncbi.nlm.nih.gov/pubmed/27276714 http://dx.doi.org/10.18632/oncotarget.9802 |
Ejemplares similares
-
SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013) -
The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy
por: Smith, Heath A., et al.
Publicado: (2010) -
Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells
por: Rekoske, Brian, et al.
Publicado: (2013) -
β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015) -
Hyperosmotic stress induces epithelial-mesenchymal transition through rearrangements of focal adhesions in tubular epithelial cells
por: Miyano, Takashi, et al.
Publicado: (2021)